Henrik Ancher-Jensen
Corporate Officer/Principal bei AGILENT TECHNOLOGIES, INC.
Vermögen: 11 Mio $ am 30.04.2024
Profil
Henrik Ancher-Jensen is currently working as the SVP & President-Order Fulfillment & Supply Chain at Agilent Technologies, Inc. He previously worked as the Vice President-Global Operations at Dako Denmark ApS from 2010 to 2012.
Mr. Ancher-Jensen completed his undergraduate degree at the University of Aarhus.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
03.05.2024 | 82 560 ( 0,03% ) | 11 Mio $ | 30.04.2024 |
Aktive Positionen von Henrik Ancher-Jensen
Unternehmen | Position | Beginn |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.09.2012 |
Ehemalige bekannte Positionen von Henrik Ancher-Jensen
Unternehmen | Position | Ende |
---|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Geschäftsführer | 01.09.2012 |
Ausbildung von Henrik Ancher-Jensen
University of Aarhus | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |